Variable | No hard event (n=99) | Hard event (n=31) | P value |
Sex | 0.11 | ||
Female | 48 (49%) | 21 (68%) | |
Male | 50 (51%) | 10 (32%) | |
Age at Cath | 8.51±6.36 | 10.29±6.14 | 0.17 |
Aetiology | 0.02 | ||
IPAH/HPAH | 39 (39%) | 20 (65%) | |
APAH | 60 (61%) | 11 (35%) | |
Time to follow-up or event | 5.36±2.67 | 2.35±2.22 | <0.0001 |
Ees/Ea_(Kind) | 1.64±0.66 | 1.41±0.45 | 0.0345 |
Ees/Ea_(Takeuchi) | 1.0±0.61 | 0.73±0.51 | 0.0182 |
PVRi, Pa s/m³ | 6.15±4.5 | 15.68±10.64 | <0.0001 |
Data are expressed as mean values (SD), n (%), unless otherwise noted.
Bold p-values indicate significance.
APAH, associated pulmonary arterial hypertension; Ees/Ea_(Kind), vascular–ventricular coupling ratio Kind method; Ees/Ea_(Takeuchi), vascular–ventricular coupling Takeuchi method; IPAH/HPAH, idiopathic and hereditary pulmonary arterial hypertension; PVRi, indexed pulmonary vascular resistance.